ABT catalyst calendar
Clinical trials led by listed companies, by the completion date the sponsor registered on ClinicalTrials.gov, soonest first, from today. Most future dates are the sponsor's estimate and can move.
November 2026
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Nov 28, 2026Sponsor estimate | NCT06888687Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.Australian Catholic University · Type 2 Diabetes Mellitus (T2DM) | ABTCollaborator | No phase registered | Active, not recruiting | Locked | Locked | Locked |
- Primary completion Nov 28, 2026Sponsor estimateNo phase registeredNCT06888687Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.Australian Catholic University · Type 2 Diabetes Mellitus (T2DM)Active, not recruitingABTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
December 2026
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Dec 2026Sponsor estimate | NCT03271762Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for...Nantes University Hospital · Mitral Regurgitation | ABTCollaborator | No phase registered | Active, not recruiting | Locked | Locked | Locked |
| Dec 30, 2026Sponsor estimate | NCT04959552FSL2 Post Approval Study for Pediatric and Young Adults PatientsAbbott Diabetes Care · Diabete Mellitus | ABTLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
| Dec 31, 2026Sponsor estimate | NCT05040087Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)Foundation for Atlanta Veterans Education and Research, Inc. · Type 2 Diabetes | ABTCollaborator | No phase registered | Active, not recruiting | Locked | Locked | Locked |
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT03271762Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for...Nantes University Hospital · Mitral RegurgitationActive, not recruitingABTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2026Sponsor estimateNo phase registeredNCT04959552FSL2 Post Approval Study for Pediatric and Young Adults PatientsAbbott Diabetes Care · Diabete MellitusActive, not recruitingABTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimateNo phase registeredNCT05040087Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)Foundation for Atlanta Veterans Education and Research, Inc. · Type 2 DiabetesActive, not recruitingABTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
January 2027
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jan 2027Sponsor estimate | NCT06106594VOLT CE Mark StudyAbbott Medical Devices · Atrial Arrhythmia | ABTLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
| Jan 31, 2027Sponsor estimate | NCT05027984Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACSCentro per la Lotta Contro l'Infarto - Fondazione Onlus · Coronary Artery Disease | ABTCollaborator | No phase registered | Active, not recruiting | Locked | Locked | Locked |
| Jan 31, 2027Sponsor estimate | NCT07373353A Clinical Evaluation of AMJ-401Abbott Medical Devices · Ischemic Heart Disease (IHD) | ABTLead | No phase registered | Active, not recruiting | Locked | Locked | Locked |
- Primary completion Jan 2027Sponsor estimateNo phase registeredNCT06106594VOLT CE Mark StudyAbbott Medical Devices · Atrial ArrhythmiaActive, not recruitingABTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2027Sponsor estimateNo phase registeredNCT05027984Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACSCentro per la Lotta Contro l'Infarto - Fondazione Onlus · Coronary Artery DiseaseActive, not recruitingABTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2027Sponsor estimateNo phase registeredNCT07373353A Clinical Evaluation of AMJ-401Abbott Medical Devices · Ischemic Heart Disease (IHD)Active, not recruitingABTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerHow to read this calendar
Completion dates as registered on ClinicalTrials.gov by the sponsor, for trials Signal8 links to a listed company. Most future dates are the sponsor's estimate and move. A completion date is when the last participant is measured, not when results are announced.
The window starts today. A date the sponsor registered to the day is listed when it falls inside the window; a date that has already passed is never listed as upcoming, even when the sponsor has not updated it yet. A date registered to the month only (shown as, say, Dec 2026) could be any day of that month, so it is listed only when the whole month falls inside the window. TrialScanner never adds a day the sponsor did not register.
By default the list shows trials where a listed company is the lead sponsor. Trials a listed company only collaborates on (as a partner, drug supplier or contract research organization) are added with the role filter, and every company is labelled Lead or Collaborator.
Free readers see the first 25 trials of any filter and windows up to 90 days, with the trial, phase, status, sponsor and primary completion. Enrollment, interventions, the start and completion dates, longer windows and later pages are part of the plan. See the methodology.